Primary Sjögren Syndrome Clinical Trial
Official title:
Effectiveness of Resistance Exercise in Daily Motor Activity Index and Functional Fitness in Women With Primary Sjögren Syndrome: a Randomized Clinical Trial
Verified date | April 2017 |
Source | Federal University of São Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To analyze the effectiveness of 16-week resistance exercise in daily motor behavior and functional fitness in women with Primary Sjögren's Syndrome. The present study presents as hypothesis that a supervised resistance exercise program is effective and safe in improving the functional fitness and quality of life of patients with Primary Sjögren's Syndrome, making them more physically active, contributing positively to the capacity to perform daily life activities as household and / or professional tasks.
Status | Completed |
Enrollment | 51 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with a diagnosis of PSS - according to the criteria of the American-European Society for the classification of Primary Sjögren's Syndrome (Vitali et al., 2002); - Female gender - Aged above 18 years Exclusion Criteria: - Patients who had cognitive difficulties, with diagnosis of Secondary Sjögren's Syndrome, - A regular physical exercise practitioner or who were practicing physical exercise regularly up to 2 months before the interview. - Patients in clinical conditions that prevented the practice of physical exercise according to previous medical evaluation, such as decompensated diabetes mellitus, decompensated thyroid disease, severe cardiorespiratory diseases, etc. - Use of medications that interfere with physical aspects, especially in response to the sensation of fatigue. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Federal University of São Paulo |
Baillet A, Vaillant M, Guinot M, Juvin R, Gaudin P. Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford). 2012 Mar;51(3):519-27. doi: 10.1093/rheumatology/ker330. Epub 2011 Nov 24. — View Citation
Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F, Markusse HM. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis. 1998 May;57(5):291-5. — View Citation
Belenguer R, Ramos-Casals M, Brito-Zerón P, del Pino J, Sentís J, Aguiló S, Font J. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome. Clin Exp Rheumatol. 2005 May-Jun;23(3 — View Citation
Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012 Apr;2(2):1143-211. doi: 10.1002/cphy.c110025. Review. — View Citation
Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Bergé E, Pellet J, Hardy P, Mariette X. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum — View Citation
Cook DB, Nagelkirk PR, Poluri A, Mores J, Natelson BH. The influence of aerobic fitness and fibromyalgia on cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome. Arthritis Rheum. 2006 Oct;54(10):3351-62. — View Citation
d'Elia HF, Rehnberg E, Kvist G, Ericsson A, Konttinen Y, Mannerkorpi K. Fatigue and blood pressure in primary Sjogren's syndrome. Scand J Rheumatol. 2008 Jul-Aug;37(4):284-92. doi: 10.1080/03009740801907995. — View Citation
Dassouki T, Benatti FB, Pinto AJ, Roschel H, Lima FR, Augusto K, Pasoto S, Pereira RMR, Gualano B, de Sá Pinto AL. Objectively measured physical activity and its influence on physical capacity and clinical parameters in patients with primary Sjögren's syn — View Citation
Hackett KL, Newton JL, Frith J, Elliott C, Lendrem D, Foggo H, Edgar S, Mitchell S, Ng WF. Impaired functional status in primary Sjögren's syndrome. Arthritis Care Res (Hoboken). 2012 Nov;64(11):1760-4. doi: 10.1002/acr.21738. — View Citation
Häkkinen A, Sokka T, Kautiainen H, Kotaniemi A, Hannonen P. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up. Ann Rheum Dis. 2004 Aug;63(8):910- — View Citation
Lendrem D, Mitchell S, McMeekin P, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Mi — View Citation
O'Grady M, Fletcher J, Ortiz S. Therapeutic and physical fitness exercise prescription for older adults with joint disease: an evidence-based approach. Rheum Dis Clin North Am. 2000 Aug;26(3):617-46. Review. — View Citation
Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev. 2010 Jul;9(3):226-37. doi: 10.1016/j.arr.2010.03.004. Epub 2010 Apr 10. Review. — View Citation
Rooks DS, Silverman CB, Kantrowitz FG. The effects of progressive strength training and aerobic exercise on muscle strength and cardiovascular fitness in women with fibromyalgia: a pilot study. Arthritis Rheum. 2002 Feb;47(1):22-8. — View Citation
Stenström CH, Minor MA. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis Rheum. 2003 Jun 15;49(3):428-34. Review. — View Citation
* Note: There are 15 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in functional fitness | The protocol consists of a sequence of 7 tests that aim to mimic the neuromotor and cardiorespiratory needs involved in the daily life activities. This battrey test was designed and validated to evaluate the elderly without a ceiling effect, ensuring that the physical aspect measured represents the maximum of the individual. The physiological components evaluated, based on the physical abilities performed in the daily activities are: upper and lower limb strength, aerobic capacity, upper and lower limb flexibility, as well as motor agility / dynamic balance. In addition, the authors added the body mass index (BMI), to estimate the body composition. |
The subjects were assessed in 2 moments: before entering the resistance training program and after 16 weeks of intervention. | |
Primary | Change in daily motor activity index | To verify the daily movement index of the subjects we used a device called an actigraphy or actimeter. | The subjects were assessed for 15 consecutive days belonging to the habitual routine of the volunteers. It was used in 2 moments: before entering the resistance training program and after 16 weeks of intervention. | |
Secondary | Quality of life estimate | To evaluate the quality of life, the "Medical Outcomes Study SF-36", a generic questionnaire was translated and validated for the Brazilian population (Ciconelli, 1999). To evaluate, in a generic way, the quality of life. It is a multidimensional instrument composed of 36 items evaluating in 8 dimensions thus distributed: 10 items related to functional capacity; 4 physical appearance items; 2 items on pain; 5 items related to general health status; 4 items on vitality; 2 items with respect to social aspects; 3 items on emotional aspects; 5 items related to mental health and one more question of comparative evaluation between the current health conditions and that of a year ago. | The subjects were assessed in 2 moments: before entering the resistance training program and after 16 weeks of intervention. | |
Secondary | Estimates of disease activity | ESSDAI - Sjögren's Syndrome Disease Activity Index is a questionnaire that investigates the activity of SSP disease and has 12 domains (constitutional, lymphadenopathy, glandular, articular, cutaneous, respiratory, renal, muscular, peripheral nervous system, central nervous system, hematological, biological) (Seror et al. 2009). It was developed from a consensus study of the EULAR (European League Against Rheumatism) and the American group. His cross-cultural adaptation and validity for the Brazilian Portuguese language was performed by the Sjögren's syndrome clinic of the Rheumatology department of the Cassiano Antônio de Moraes University Hospital (HUCAM), in Vitória, Espírito Santo (Serrano et al., 2013). Disease activity is classified into 3 levels: mildly active, moderately active and highly active. | The subjects were assessed in 2 moments: before entering the resistance training program and after 16 weeks of intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06440525 -
A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT03140111 -
LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients
|
N/A | |
Not yet recruiting |
NCT06049368 -
68Ga-P16-093 PET/CT Imaging in the Salivary Gland
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03614299 -
Eye Dryness Evaluation in Primary Sjögren's Syndrome
|
||
Not yet recruiting |
NCT03126383 -
Inflammatory Myopathies in Primary Sjögren's Syndrome
|
N/A | |
Recruiting |
NCT04830644 -
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
|
Phase 2 | |
Not yet recruiting |
NCT03765593 -
Biomarkers in Primary Sjögren's Syndrome
|
||
Completed |
NCT01081184 -
Neurotrophins Implications in Primary Sjögren Syndrome
|
N/A | |
Completed |
NCT05670535 -
Sjögren and Gynecologic Considerations
|
||
Completed |
NCT03226444 -
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT04816370 -
Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions
|
N/A | |
Completed |
NCT05380804 -
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
|
||
Terminated |
NCT04700280 -
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
|
Phase 2 | |
Completed |
NCT04093531 -
Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
|
Phase 1 | |
Recruiting |
NCT03509064 -
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
|
||
Completed |
NCT04224454 -
Vaccine Coverage and Primary Sjögren'Syndrome
|
||
Completed |
NCT04960605 -
Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome
|
N/A | |
Recruiting |
NCT06361745 -
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
|
N/A |